| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |